Indeed, several recent studies have shown that targeting the RBD with soluble ACE2 [176], including computationally modified ACE2 [177], mini-proteins [178], neutralizing antibodies [179,180,181], nanobodies [182] and aptamers [183,184], can prevent infection. This evidence concerns the gene ACE2 and infection.